| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
AVTR
Avantor
|
Sep 09, 2026 | HOLD |
Buy
+4.5% avg upside
26 analysts
|
$15.50
2.75% Upside
|
+4.3% | · |
|
NTRA
Natera
|
Sep 09, 2026 | BUY |
Strong Buy
-14.5% avg upside
28 analysts
|
$365.00
1.53% Downside
|
+12.2% | · |
|
GH
Guardant Health
|
Sep 09, 2026 | BUY |
Strong Buy
-4.1% avg upside
32 analysts
|
$210.00
20.76% Upside
|
+6.8% | · |
|
A
Agilent
|
Sep 09, 2026 | BUY |
Strong Buy
-10.0% avg upside
34 analysts
|
$180.00
11.13% Upside
|
+11.9% | · |
|
ILMN
Illumina
|
Sep 09, 2026 | HOLD |
Buy
-25.1% avg upside
31 analysts
|
$215.00
9.95% Downside
|
+16.5% | · |
|
RVTY
Revvity
|
Sep 09, 2026 | HOLD |
Buy
-19.8% avg upside
23 analysts
|
$120.00
16.47% Downside
|
+15.9% | · |
|
TMO
Thermo Fisher
|
Sep 09, 2026 | HOLD |
Strong Buy
-6.8% avg upside
40 analysts
|
$575.00
12.72% Downside
|
+7.6% | · |
|
WAT
Waters
|
Sep 09, 2026 | BUY |
Strong Buy
-5.6% avg upside
31 analysts
|
$450.00
6.06% Upside
|
+4.2% | · |
|
PACB
Pacific Biosciences
|
Aug 08, 2025 | BUY |
Buy
+230.2% avg upside
14 analysts
|
$1.70
24.92% Upside
|
-11.8% | · |
|
DE:SRT3
Sartorius
|
Jan 06, 2025 | SELL |
Buy
+12.3% avg upside
19 analysts
|
$194.00
21.74% Downside
|
-14.5% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.